1. Oncogenic driver mutations in Swiss never smoker patients with lung adenocarcinoma and correlation with clinicopathologic characteristics and outcome
   Claudia Grosse et al, 2019, PLOS ONE CrossRef
2. Efficacy of bronchoscopic biopsy for the detection of epidermal growth factor receptor mutations and anaplastic lymphoma kinase gene rearrangement in lung adenocarcinoma
   Pei Zhu et al, 2015, Thoracic Cancer CrossRef
3. Effect of Asbestos Exposure on the Frequency of EGFR Mutations and ALK/ROS1 Rearrangements in Patients With Lung Adenocarcinoma
   Senay Yilmaz et al, 2021, Journal of Occupational & Environmental Medicine CrossRef
4. Relationship of epidermal growth factor receptor activating mutations with histologic subtyping according to International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society 2011 adenocarcinoma classification and their impact on overall survival
   Navneet Singh et al, 2016, Lung India CrossRef
5. Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland
   Alexandra Grosse et al, 2019, Diagnostic Pathology CrossRef
6. Could molecular pathology testing in lung cancer be more cost-effective?
   Kathy Walsh et al, 2016, Journal of Clinical Pathology CrossRef
7. EGFR T790M detection in formalin‐fixed paraffin‐embedded tissues of patients with lung cancer using RNA‐based in situ hybridization: A preliminary feasibility study
   Shafei Wu et al, 2019, Thoracic Cancer CrossRef
8. Correlation of Thyroid Transcription Factor-1 Expression with EGFR Mutations in Non-Small-Cell Lung Cancer: A Meta-Analysis
   Hyeong Su Kim et al, 2019, Medicina CrossRef
9. Large-Scale EGFR Mutation Testing in Clinical Practice: Analysis of a Series of 18,920 Non-Small Cell Lung Cancer Cases
   Matthew Evans et al, 2019, Pathology & Oncology Research CrossRef
10. Analysis of the frequency of EGFR, KRAS and ALK mutations in patients with lung adenocarcinoma in Croatia
    Luka Brcic et al, 2016, Diagnostic Pathology CrossRef
11. The Relationship between TTF-1 Expression and EGFR Mutations in Lung Adenocarcinomas
    Wan Shanzhi et al, 2014, PLoS ONE CrossRef
12. Prevalence of EGFR mutations in newly diagnosed locally advanced or metastatic non-small cell lung cancer Spanish patients and its association with histological subtypes and clinical features: The Spanish REASON study
    E. Esteban et al, 2015, Cancer Epidemiology CrossRef
13. Adequacy and Utilization of Small Biopsy Material for Molecular Diagnosis
    Gilda da Cunha Santos, 2015, Diagnosing Non-small Cell Carcinoma in Small Biopsy and Cytology CrossRef
14. Suitability of Surgical Tumor Tissues, Biopsy, or Cytology Samples for Epidermal Growth Factor Receptor Mutation Testing in Non–Small Cell Lung Carcinoma Based on Chinese Population
    Xiaohong Han et al, 2014, Translational Oncology CrossRef
15. Clinical Characteristics, Tumor, Node, Metastasis Status, and Mutation Rate in Domain of Epidermal Growth Factor Receptor Gene in Serbian Patients with Lung Adenocarcinoma
    Bojan Zaric et al, 2014, Journal of Thoracic Oncology CrossRef
16. Erlotinib for Patients with EGFR Wild-Type Metastatic NSCLC: a Retrospective Biomarkers Analysis
    Alessandro Inno et al, 2019, Pathology & Oncology Research CrossRef
17. Distribution of EGFR Mutations in 10,607 Russian Patients with Lung Cancer
    Evgeny N. Imyanitov et al, 2016, Molecular Diagnosis & Therapy CrossRef
18. Genotyping of EGFR Mutations from Bronchial Cytological Specimens in Slovakian Lung Cancer Patients
    K. Baluchova et al, 2016, Pulmonary Dysfunction and Disease CrossRef
19. Efficiency of the Therascreen® RGQ PCR kit for the detection of EGFR mutations in non-small cell lung carcinomas
    Audrey Vallée et al, 2014, Clinica Chimica Acta CrossRef
20. Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patients
    Anna Estival et al, 2019, Scientific Reports CrossRef
21. Clinicopathologic Features and Molecular Biomarkers as Predictors of Epidermal Growth Factor Receptor Gene Mutation in Non-Small Cell Lung Cancer Patients
    Lanlan Liu et al, 2021, Current Oncology CrossRef
22. Molecular profiling of patients with advanced lung adenocarcinoma diagnosed between 2015 and 2020 in French Polynesia
    Merouane Messekher et al, 2023, Respiratory Medicine and Research CrossRef
23. Outsourcing cytological samples to a referral laboratory for EGFR testing in non‐small cell lung cancer: does theory meet practice?
    E. Vigliar et al, 2015, Cytopathology CrossRef
24. EGFR T790M resistance mutation in non small-cell lung carcinoma
    Marc G. Denis et al, 2015, Clinica Chimica Acta CrossRef